Latest

Mar 28, 2017
By Pharmaceutical Executive Editors
The development of highly effective cures for hepatitis C has prompted a panel of experts to propose an innovative financing arrangement to make these therapies more available to “neglected” populations in the U.S.
Mar 22, 2017
In-market experimentation is the best way to address the challenge of pitching brand leaders on new ways to reach their target population through digital and other non-personal channels, write Scott Beauchamp and Michael Calamari.
Mar 17, 2017
Jeff R. Livingstone outlines the critical steps necessary to ensure an agile, responsive and streamlined supply chain.
Mar 09, 2017
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Facing mixed market signals, biotech companies look to rise above the fray in advancing new-wave discoveries to the clinical finish line.
Feb 28, 2017
Laurent Fanichet outlines four ways pharma companies can use cognitive search and search-based applications to improve competitiveness.
Feb 21, 2017
The risk of non-compliance with export controls, and the associated civil and criminal penalties, are very real given the sensitive and global nature of the biopharmaceutical industry’s work. This article outlines steps companies should take to ensure compliance with export controls.
Feb 06, 2017
From Applied Clinical Trials
The temptation to use uncontrolled, early, small studies to support further development of products may prove problematic for emerging biopharma companies.
Feb 03, 2017
Pharmaceutical Executive
There are question marks when trying to size up the trajectory of the global pharma industry in 2017. One certainty, however, will be change.
Feb 02, 2017
This article provides an overview of the Procedural Guidance from the FDA “Medical Product Communications That are Consistent with the FDA Required Labeling,”released early this year. In addition to providing a list of three factors manufacturers should use to determine if product communications are consistent with the FDA-required labeling, FDA clarifies what is meant by information consistent with the FDA-required labeling.
Jan 24, 2017
From Applied Clinical Trials
The Expert Determination standard of protecting patient privacy can answer the growing demand for better data for research and analytics in healthcare.
native1_300x100
lorem ipsum